OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
4
Results
Show all
Save search
Copy query
Show results for
Transcriptomics
(2)
Unknown
(2)
Organisms
Homo sapiens
(2)
Repository
biostudies-arrayexpress
(2)
Instrument Platform
Illumina HiSeq 2500
(1)
Publication Date
2024
(2)
Study type
Transcription profiling by array
(1)
RNA-seq of coding RNA
(1)
Release Date
2024
(2)
2018
(1)
2015
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
High-Dose Chemotherapy and Blood Autologous Stem-Cell Rescue Compared With Standard Chemotherapy in Localized High-Risk Ewing Sarcoma: Results of Euro-E.W.I.N.G.99 and Ewing-2008.
Not available
S-EPMC6209090
|
biostudies-literature
Cite
Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial.
Not available
S-EPMC4486345
|
biostudies-literature
Cite
RNA-seq profiling of Malignant Rhabdoid Tumours
An observational experiment to methylation profile 23 SMARCB1 negative primary tumours from patients diagnosed with Malignant Rhabdoid Tumours.
ORGANISM(S):
Homo sapiens
2024-12-31
|
E-MTAB-6775
|
biostudies-arrayexpress
Cite
Expression profiling following SMARCB1 re-expression in MRT cell lines time course over 14 days
MRT cell lines KD, SWOH, LM, DEV and G401 were expression profiled following SMARCB1 re-expression using a lentivirus. Samples were taken at Day 0,1,3,7 and 14 and compared to empty vector control experiments.
ORGANISM(S):
Homo sapiens
2024-12-31
|
E-MTAB-6674
|
biostudies-arrayexpress
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets